These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32565895)
21. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients. May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719 [TBL] [Abstract][Full Text] [Related]
22. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland. Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788 [TBL] [Abstract][Full Text] [Related]
23. Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy. Peng LC; Narang AK; Gergis C; Radwan NA; Han P; Marciscano AE; Robertson SP; He P; Trieu J; Ram AN; McNutt TR; Griffith E; DeWeese TA; Honig S; Singh H; Greco SC; Tran PT; Deville C; DeWeese TL; Song DY Urol Oncol; 2018 Jun; 36(6):309.e7-309.e14. PubMed ID: 29551548 [TBL] [Abstract][Full Text] [Related]
24. Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data. Loblaw A; Pickles T; Crook J; Martin AG; Vigneault E; Souhami L; Cury F; Morris J; Catton C; Lukka H; Cheung P; Sethukavalan P; Warner A; Yang Y; Rodrigues G; Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):161-170. PubMed ID: 27780694 [TBL] [Abstract][Full Text] [Related]
25. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis. Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107 [TBL] [Abstract][Full Text] [Related]
26. How localized is pathologically localized prostate cancer? The use of secondary circulating prostate cells as a marker of minimal residual disease and their association with patient outcome. Murray NP; Aedo S; Fuentealba C; Reyes E; Jacob O Turk J Urol; 2017 Dec; 43(4):456-461. PubMed ID: 29201508 [TBL] [Abstract][Full Text] [Related]
27. External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort. Tilki D; Mandel P; Schlomm T; Chun FK; Tennstedt P; Pehrke D; Haese A; Huland H; Graefen M; Salomon G J Urol; 2015 Jun; 193(6):1970-5. PubMed ID: 25498570 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of biochemical recurrence-free survival after radical prostatectomy by cancer of the prostate risk assessment post-surgical (CAPRA-S) score. Aktas BK; Ozden C; Bulut S; Tagci S; Erbay G; Gokkaya CS; Baykam MM; Memis A Asian Pac J Cancer Prev; 2015; 16(6):2527-30. PubMed ID: 25824791 [TBL] [Abstract][Full Text] [Related]
29. Analysis of the Cancer of the Prostate Risk Assessment to predict for biochemical failure after external beam radiotherapy or prostate seed brachytherapy. Delouya G; Krishnan V; Bahary JP; Larrivée S; Taussky D Urology; 2014 Sep; 84(3):629-33. PubMed ID: 25168545 [TBL] [Abstract][Full Text] [Related]
30. External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer. Tiberi D; Rodrigues G; Pickles T; Morris J; Crook J; Martin AG; Cury F; Catton C; Lukka H; Warner A; Taussky D Can Urol Assoc J; 2017; 11(3-4):94-100. PubMed ID: 28515807 [TBL] [Abstract][Full Text] [Related]
31. [Outcomes and predictors of T3a prostate cancer treated by permanent interstitial brachytherapy combined with external radiotherapy and hormone therapy]. Mai Z; Yan W; Li H; Zhou Y; Zhou Z; Chen J Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):765-70. PubMed ID: 25573217 [TBL] [Abstract][Full Text] [Related]
32. Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated with Surgery alone. Murray NP; Villalon R; Orrego S; Guzman E Asian Pac J Cancer Prev; 2021 Aug; 22(8):2391-2397. PubMed ID: 34452551 [TBL] [Abstract][Full Text] [Related]
33. 10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy. Murray NP; Aedo S; Fuentealba C; Reyes E Asian Pac J Cancer Prev; 2018 Jun; 19(6):1577-1583. PubMed ID: 29936782 [TBL] [Abstract][Full Text] [Related]
34. Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone. Murray NP; Aedo S; Villalon R; Albarran V; Orrego S; Guzman E Ecancermedicalscience; 2020; 14():1119. PubMed ID: 33209110 [TBL] [Abstract][Full Text] [Related]
35. Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients. Budäus L; Isbarn H; Tennstedt P; Salomon G; Schlomm T; Steuber T; Haese A; Chun F; Fisch M; Michl U; Heinzer H; Huland H; Graefen M BJU Int; 2012 Dec; 110(11):1714-20. PubMed ID: 22520619 [TBL] [Abstract][Full Text] [Related]
36. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Punnen S; Freedland SJ; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Carroll PR; Cooperberg MR Eur Urol; 2014 Jun; 65(6):1171-7. PubMed ID: 23587869 [TBL] [Abstract][Full Text] [Related]
37. Accuracy of CAPRA-S Score for Predicting Long-Term Biochemical Progression After Radical Prostatectomy. Hernández Hernández C; Kim Lee D; Sanchez Pérez M; Escobar SH Clin Genitourin Cancer; 2019 Jun; 17(3):e645-e649. PubMed ID: 31097389 [TBL] [Abstract][Full Text] [Related]